Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

NCT06293287 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Radial Artery Occlusion

Interventions

DRUG: Subcutaneous enoxaparin sodium
DRUG: Placebo

Sponsor

Zhongshan Hospital (Xiamen), Fudan University